Next-Gen Point Of Care Infectious Disease Testing: Market Forecast, Transformation, and Long-Term Trajectories
We’ve updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Are the Key Projections for the CAGR of the Point Of Care Infectious Disease Testing Market Size From 2025 to 2034?
The market size for point of care infectious disease testing has been expanding rapidly in the recent years. It is predicted to surge from $4.21 billion in 2024 to $4.79 billion in 2025, registering a compound annual growth rate (CAGR) of 14.0%. Factors contributing to the growth observed in the historic period include a surge in demand for fast diagnostic solutions, increasing prevalence of infectious diseases, growing health consciousness, escalation in healthcare spending, and a rise in the adoption rate of home care and self-testing solutions.
The market size for point of care infectious disease testing is predicted to experience swift expansion in the upcoming years, mushrooming to $8.02 billion in 2029. The compound annual growth rate (CAGR) stands at 13.7%. Factors contributing to such growth during this projection period include the soaring demand for rapid diagnostic techniques, an increase in the cases of infectious diseases, wider adoption in isolated and resource-constrained environments, a transition towards localized healthcare, and the positive role of government initiatives and funding. The impending period also exhibits major advancements in molecular diagnostics, state-of-the-art point of care testing equipment, innovations in biosensors and detection methodologies, development in mobile health applications, and creative alliances between healthcare professionals and technology firms.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24382&type=smp
Which Major Market Drivers Are Expected to Boost the Growth Potential of the Point Of Care Infectious Disease Testing Market?
Expectations are that the escalating prevalence of contagious diseases will boost the expansion of the point of care infectious disease testing market. Contagious illnesses are diseases that can be transmitted from one individual to another through direct touch, aerosols in the air, or other transmission methods. The surge in such illnesses is largely due to the increase in human mobility since a higher frequency of people traveling between regions and countries enables the quicker and broader spread of infectious agents. Point of care testing for infectious diseases hastens the identification and diagnosis of such illnesses, facilitating prompt treatment and diminishing the likelihood of transmission within communities. For instance, as per data from the UK Health Security Agency, a governmental organization in the UK, from the 40th week of 2022 to the 15th week of 2023, 108 NHS trusts in England documented 1,681 critical care admissions due to verified cases of influenza. In contrast, the previous influenza season saw only 182 admissions across 114 trusts, which rose to 316 by the 39th week of 2022. Hence, it’s evident that the surge in contagious illnesses is fueling the growth of the point of care infectious disease testing market.
Which Key Market Segments Comprise the Point Of Care Infectious Disease Testing Market and Drive Its Revenue Growth?
The point of care infectious disease testing market covered in this report is segmented –
1) By Product: Kits And Reagents, Instruments
2) By Technology: Lateral Flow Immunoassay, Agglutination Test, Flow-through Test Or Immunoconcentration Assay, Molecular Diagnostics, Other Technologies
3) By Disease: Human Immunodeficiency Virus Point-of-Care Testing, Clostridium Difficile Point-of-Care Testing, Hepatitis B Virus Point-of-Care Testing, Pneumonia or Streptococcus Associated Infections, Respiratory Syncytial Virus Point-of-Care Testing, Human Papillomavirus Point-of-Care Testing, Influenza Or Flu Point-of-Care Testing, Other Diseases
4) By End Use: Hospitals, Diagnostic Centers, Research and Academic Institutes, Homecare Settings, Other End Users
Subsegments:
1) By Kits And Reagents: Test Kits, Reagents
2) By Instruments: Portable Devices, Automated Analyzers
Request customized data on this market:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24382&type=smp
Which Areas Are Leading Regions in the Point Of Care Infectious Disease Testing Market Expansion Across the Globe?
North America was the largest region in the point of care infectious disease testing market in 2024. Asia-Pacific is expected to be the Fastest-Growing region in the forecast period. The regions covered in the point of care infectious disease testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Key Market Trends in the Point Of Care Infectious Disease Testing Market Over the Coming Years?
Significant players in the point-of-care infectious disease testing market are concentrating on incorporating ground-breaking technologies like proprietary microfluidic technology to augment test precision, decrease time-to-outcomes, and uplift patient results. Proprietary microfluidic technology is a technique handling tiny volumes of fluids at the microscale, leading to swift, accurate, and economical diagnostic analysis, favouring point of care (POC) infectious disease testing. This technology simplifies on-the-spot, speedy detection of pathogens with amalgamated sample gathering, examination, and result generation, thus enhancing the pace and availability of diagnostics by eliminating the need for centralized laboratory tests. As an illustration, the Sysmex Corporation, which is a diagnostic company based in Japan, released the PA-100 AST System in Europe in June 2023, debuting as the world’s first solution for point-of-care testing that accurately detects antimicrobial susceptibility. With the use of advanced microfluidic technology, the system expedites identification of bacterial infections and assessment of antimicrobial effectiveness, which considerably diminishes processing time in comparison to traditional techniques. The system boasts a concise, desktop-sized analyzer and cartridges for single-use sample collection, making it ideal for near-patient environments like primary care clinics. The system is engineered to enable faster and precise decisions on antimicrobial therapy and contributes to global initiatives to tackle antimicrobial resistance by enhancing diagnostic productivity.
View the full report here:
How Is the Point Of Care Infectious Disease Testing Market Conceptually Defined?
Point of care (POC) infectious disease testing refers to diagnostic tests that are performed at or near the site of patient care, such as hospitals, clinics, doctors’ offices, or even at home. These tests are designed to detect infectious diseases quickly and accurately, providing immediate results to facilitate prompt treatment decisions. POC tests are typically user-friendly, require minimal equipment, and offer results within minutes to hours, making them ideal for situations where timely diagnosis is crucial.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/customise?id=24382&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
